Welcome to the Rani Fourth Quarter and Full Year 2025 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, March 26, 2026.

Announced up to $1.085 billion collaboration with Chugai Pharmaceutical Co. for multiple high-value therapeutics and completed $60.3 million ...

Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it ...

PUTNEY — Next Stage Arts and Twilight Music present New England’s acclaimed folk/roots quartet Rani Arbo & daisy mayhem at Next Stage on Saturday, Feb. 1, at 7:30 p.m. Rani Arbo & daisy mayhem feature ...

Rani Therapeutics Holdings recently announced a collaboration and license agreement with Chugai Pharmaceutical for the joint development and commercialization of an oral product combining Rani’s ...

With investors perched on the edge of their seats for months, Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) announces a deal including upfront milestones and partner-funded asset development. On ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and ...